Evidence map›Paper›PMID 25047814›Full record

ArticleChemMedChem2014

Structural and biochemical studies of actin in complex with synthetic macrolide tail analogues.

Jose H Pereira, Chutima Petchprayoon, Alexander C Hoepker, Nigel W Moriarty, Sarah J Fink, Giuseppe Cecere, Ian Paterson, Paul D Adams, Gerard Marriott

Open access · greenAbstract read
In one paragraph

Article in ChemMedChem, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Next Generation Opto-Jasplakinolides Enable Local Remodeling of Actin Networks.Angewandte Chemie (International ed. in English) · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jose H PereiraPhysical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 (USA).
Chutima Petchprayoon
Alexander C Hoepker
Nigel W Moriarty
Sarah J Fink
Giuseppe Cecere
Ian Paterson
Paul D Adams
Gerard Marriott
Lawrence Berkeley National Laboratory · USUniversity of California, Berkeley · USUniversity of Cambridge · GB

Funding

New probes for optical switching of protein interactions and protein fluorescenceR01EB005217 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI MARRIOTT, GERARD · 2006 to 2009
$1.6M
New Classes of Genetically-Encoded Fluorescence Anisotropy ProbeR21EB017387 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARRIOTT, GERARD · 2014 to 2015
$431k
NIBIB NIH HHS 5R01EB005217NIBIB NIH HHS R01 EB005217NIBIB NIH HHS R21 EB017387
6 · The paper itself

Abstract

The actin filament-binding and filament-severing activities of the aplyronine, kabiramide, and reidispongiolide families of marine macrolides are located within the hydrophobic tail region of the molecule. Two synthetic tail analogues of aplyronine C (SF-01 and GC-04) are shown to bind to G-actin with dissociation constants of (285±33) and (132±13) nM, respectively. The crystal structures of actin complexes with GC-04, SF-01, and kabiramide C reveal a conserved mode of tail binding within the cleft that forms between subdomains (SD) 1 and 3. Our studies support the view that filament severing is brought about by specific binding of the tail region to the SD1/SD3 cleft on the upper protomer, which displaces loop-D from the lower protomer on the same half-filament. With previous studies showing that the GC-04 analogue can sever actin filaments, it is argued that the shorter complex lifetime of tail analogues with F-actin would make them more effective at severing filaments compared with plasma gelsolin. Structure-based analyses are used to suggest more reactive or targetable forms of GC-04 and SF-01, which may serve to boost the capacity of the serum actin scavenging system, to generate antibody conjugates against tumor cell antigens, and to decrease sputum viscosity in children with cystic fibrosis.

Indexed as

ActinsAnimalsCrystallography, X-RayMacrolidesModels, MolecularRabbitsActinsMacrolidesactinchemical synthesisdrug designmacrolide analoguesstructural biology

Identifiers

PMID25047814
PMCPMC4213943
OpenAlexW2162028331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.